| Nontumoral HCC Cohort (N = 44) | Tumor HCC Cohort (N = 43) | ||||
---|---|---|---|---|---|---|
 | Risk ratio | 95% CI | P-value | Risk ratio | 95% CI | P-value |
Tumor stage | 2.48 | 1.39-4.51 | 0.002 | 2.54 | 1.41-4.70 | 0.002 |
Tumor diameter | 1.59 | 1.17-2.09 | 0.005 | 1.65 | 1.19-2.24 | 0.004 |
Number of tumors | 2.41 | 1.17-4.68 | 0.02 | 2.10 | 0.99-4.19 | 0.05 |
Platelet count | 0.95 | 0.87-1.03 | 0.22 | 0.97 | 0.89-1.06 | 0.53 |
Sex [male] | 1.44 | 0.67-3.43 | 0.36 | 1.62 | 0.74-4.08 | 0.24 |
Indocyanine green | 1.02 | 0.97-1.06 | 0.40 | 1.01 | 0.97-1.05 | 0.56 |
Prothrombin time | 0.99 | 0.97-1.02 | 0.45 | 0.99 | 0.97-1.02 | 0.40 |
Portal vein invasion [present] | 1.41 | 0.33-4.06 | 0.59 | 1.42 | 0.34-4.08 | 0.59 |
Liver resection procedure [lobular] | 1.14 | 0.62-1.82 | 0.65 | 1.13 | 0.61-1.81 | 0.66 |
Total Bilirubin | 1.26 | 0.42-3.24 | 0.66 | 1.35 | 0.50-3.19 | 0.54 |
Fibrosis score | 0.96 | 0.65-1.49 | 0.86 | 0.92 | 0.63-1.38 | 0.67 |
Tumor differentiation [moderate-poor] | 1.08 | 0.47-2.93 | 0.86 | 0.84 | 0.35-2.49 | 0.73 |
Age | 1.00 | 0.96-1.05 | 0.90 | 1.02 | 0.97-1.07 | 0.53 |
Alanine aminotransferase | 1.00 | 0.99-1.01 | 0.96 | 1.00 | 0.99-1.01 | 0.94 |
α-Fetoprotein | 1.00 | 1.00-1.00 | 0.99 | 1.00 | 1.00-1.00 | 0.90 |